Key points are not available for this paper at this time.
You have accessJournal of UrologyKidney Cancer: Epidemiology p=0.004), 2021 – 2023 (OR: 0.08; p=0.0002) compared to 2013 – 2014 on multivariable analysis (Table 1). However, patients undergoing CN was associated with better overall survival on multivariable analysis (HR: 1.45; p=0.04) and Kaplan Meier analysis (Figure 1). CONCLUSIONS: The use of CN has substantially decreased in the United States. However, we demonstrated a decrease in OS for those not undergoing CN over a 5-year interval. Further study is needed to elucidate the role of CN moving forward as the treatment landscape continues to evolve for mRCC. Download PPT Source of Funding: Schramm Foundation © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e849 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Brett Wiesen More articles by this author Justin Achua More articles by this author Adam Warren More articles by this author Boris Gershman More articles by this author Corbin Eule More articles by this author Simon Kim More articles by this author Expand All Advertisement PDF downloadLoading ...
Wiesen et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: